过表达kisspeptin抑制MKN-45胃腺癌细胞的增殖和迁移
[Abstract]:Objective to investigate the expression of tumor metastasis inhibitor kisspeptin (KISS-1) in gastric adenocarcinoma and its effect on the proliferation and migration of gastric adenocarcinoma cells. Methods Real-time quantitative PCR and Western blot were used to detect the mRNA and protein levels of kisspeptin in 50 gastric adenocarcinoma tissues and corresponding paracancerous tissues. Kisspeptin small interfering RNA (kisspeptin-siRNA), control small RNA (control-siRNA) kisspeptin overexpression vector (p EGFP-N1-kisspeptin) and control empty vector (p EGFP-N1) were transfected into MKN-45 gastric adenocarcinoma cells, respectively. After 48 h culture, kisspeptinin, matrix metalloproteinase-9 (MMP-9) MMP-2, 尾 -catenin and C-myc protein levels were detected by Western blot assay, and cell migration was detected by cell scratch assay. Wnt/ 尾 -catenin signaling pathway inhibitor FH535 was used to detect the proliferation of gastric adenocarcinoma cells and apoptosis by flow cytometry. Results the expression of Kisspeptin in gastric adenocarcinoma was significantly lower than that in paracancerous tissues. Compared with empty vector group, the survival rate and mobility of MKN-45 cells were significantly lower than those of empty vector group, and the levels of MMP-9, MMP-2, 尾 -cateninine C-myc were significantly decreased after overexpression of kisspeptin, and the survival rate and mobility of MMP-9, MMP-2 and 尾 -cateninine C-myc were significantly increased after treatment with .FH535 compared with those in control-siRNA group. The migration trend was consistent with overexpression of kisspeptin cells. Conclusion the low expression of Kisspeptin in gastric adenocarcinoma inhibits the proliferation and migration of gastric adenocarcinoma cells through Wnt/ 尾 -catenin signaling pathway.
【作者单位】: 河北医科大学第一医院病理科;河北医科大学第一医院骨科;
【基金】:河北省卫计委青年科技课题(20150642)
【分类号】:R735.2
【相似文献】
相关期刊论文 前10条
1 刘丽华,郝国桢,王士杰,庞凤兰;血管内皮生长因子在胃腺癌中的表达及意义[J];临床荟萃;2004年23期
2 李国华,钱伟,侯晓华;胃腺癌组织中分泌血管活性肠肽的肿瘤细胞研究[J];中国实用内科杂志;2005年03期
3 胡亚斌;刘建平;;基于区域增长和改进分水岭算法的胃腺癌细胞图像分割[J];计算机与数字工程;2006年08期
4 赵亮;沈志祥;沈磊;罗和生;;胃腺癌组织瘦素、瘦素受体表达及其临床意义[J];武汉大学学报(医学版);2006年05期
5 赵亮;沈磊;沈志祥;罗和生;;瘦素在胃腺癌组织和细胞中的表达和定位[J];临床消化病杂志;2009年01期
6 张琰;宋平;李洪利;;血管活性肠肽在胃腺癌组织及细胞中的表达及意义[J];中国医药导报;2009年24期
7 陈晖;岑平;李佳荃;林瑶光;唐国都;姜海行;臧宁;冯振博;苏齐鉴;;血管活性肠肽在胃腺癌中的表达及意义[J];中国肿瘤临床;2009年03期
8 李云桥;侯晓华;王艺峰;张俐娜;;化学修饰的茯苓β-D-葡聚糖结构与抗胃腺癌活性的关系[J];世界华人消化杂志;2012年15期
9 林中;唐强;;胃腺癌细胞血循环中大量增殖1例[J];桂林医学院学报;1993年02期
10 陈丽;;胃腺癌组织中β-catenin的异常表达[J];中国临床保健杂志;2006年05期
相关会议论文 前5条
1 周红;李祺福;黄宗平;;胃腺癌细胞核骨架在细胞诱导分化过程中的变化[A];中国细胞生物学学会第五次会议论文摘要汇编[C];1992年
2 申发娟;;上调miR-200家族的表达对胃腺癌细胞系生长的体外研究[A];天津市生物医学工程学会第三十三届学术年会论文集[C];2013年
3 金焰;李明;孙文静;于e,
本文编号:2144809
本文链接:https://www.wllwen.com/yixuelunwen/zlx/2144809.html